Repetitive transcranial magnetic stimulation (rTMS) of the brain is a noninvasive, well-tolerated technique that can modify cerebral cortex ... rTMS for motor function in Parkinson disease ...

US-based pharmaceutical company AbbVie has reported that the Phase III TEMPO-2 trial of tavapadon, its D1/D5 partial agonist candidate for early-stage Parkinson's disease, met its primary endpoint.

The ability to acquire new motor skills is fundamental for adapting to our environment. This learning takes place in the primary motor ... disorders such as Parkinson's disease, where dopamine ...

For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time ...

Lewy bodies are found throughout the outer layer of the brain (the cerebral cortex) and deep inside the midbrain and brainstem. They can also be found in Alzheimer’s disease, Parkinson’s ... of life ...

This learning takes place in the primary ... motor skills throughout life. These insights could also have important implications for treating neurological disorders such as Parkinson’s disease ...

This initiative, which involves dog walking events across various Belgian cities, aimed to support individuals affected by Parkinson’s disease. Characterized by motor symptoms such as tremors ...